Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma

Published:2018-06-20 Issue:8 Volume:93 Page:1020-1028
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Ekberg Sara¹^ORCID,Jerkeman Mats²,Andersson Per-Ola³^ORCID,Enblad Gunilla⁴,Wahlin Björn E⁵,Hasselblom Sverker⁶,Andersson Therese M.⁷,Eloranta Sandra¹^ORCID,Smedby Karin E.¹⁸^ORCID

Affiliation:

1. Division of Clinical Epidemiology, Department of Medicin Solna; Karolinska Institutet; Stockholm Sweden

2. Department of Oncology and Pathology; Institute of Clinical Sciences, Lund University; Lund Sweden

3. Department of Hematology; South Älvsborg Hospital, Borås and Sahlgrenska Academy, Gothenburg University; Gothenburg Sweden

4. Department of Oncology; Akademiska University Hospital, Uppsala; Sweden

5. Division of Hematology, Deparment of Medicine Huddinge; Karolinska Institutet; Stockholm Sweden

6. Deparment of Research, Development & Education; Region Halland; Halmstad Sweden

7. Deparment of Medical Epidemiology and Biostatistics; Karolinska Institutet; Stockholm Sweden

8. Center for hematology, Karolinska University Hospital; Solna Sweden

Funder

Swedish Cancer Society

Stockholm County Council

Karolinska Institutet and Janssen Pharmaceuticals

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.25147/fullpdf

Reference22 articles.

1. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med.,2002

2. A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin's lymphomas;Feugier;Future Oncol.,2015

3. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia;Sehn;J Clin Oncol.,2005

4. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group;Pfreundschuh;Lancet Oncol.,2006

5. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma;Habermann;J Clin Oncol.,2006

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Лечение диффузной В-крупноклеточной лимфомы в условиях ГКБ № 52 Департамента здравоохранения Москвы: ретроспективное клиническое исследование, отражающее опыт одного центра, на основе анализа данных из собственного локального регистра;Clinical Oncohematology;2024-02-20

2. Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis;Leukemia;2023-12-29

3. Increase in the Life Expectancy of Patients with Cancer in the United States;Cancer Epidemiology, Biomarkers & Prevention;2023-12-13

4. Patient trajectories after diagnosis of diffuse large B-cell lymphoma—a multistate modelling approach to estimate the chance of lasting remission;British Journal of Cancer;2022-08-23

5. Assessing lead time bias due to mammography screening on estimates of loss in life expectancy;Breast Cancer Research;2022-02-23